Cuts proposed by the Trump administration and House Republicans could drive up new HIV cases by more than 200,000 by 2030, one expert projects.

In Ghana, public health campaigns have long focused on HIV/AIDS and malaria . These diseases have historically claimed thousands of lives and continue to be a concern .

In a bold step towards tackling the HIV epidemic, the Ministry of Health and Wellness is now considering a pilot programme for the first US Food and Drug Administration-approved injectable HIV ...

Two Indian drugmakers, Hetero Pharma & Dr Reddy’s Laboratories, set to produce generic lenacapavir. The generic version will be available in low- and middle-income countries at significantly lower ...

Lenacapavir has delivered impressive trial results and, in July, it received official backing from the World Health Organization for HIV prevention. The injection is taken twice a year and provides ...

A long-acting HIV jab promises near-perfect protection at just $40 a year, but 115 nations must wait for India's approval of generic production ...

Kampala, Uganda | THE INDEPENDENT & AGENCIES | A new long-acting medicine that could make preventing HIV transition might soon be even for poor countries like Uganda thanks to agreements between ...

The drug has also recently been approved by the US Food and Drug Administration, a milestone which the AIDS Commission says paves the way for national approval in Uganda to catalyse the drive to end ...

Two Indian generic drugmakers — Hetero and Dr Reddy’s — will be funded by the Gates Foundation and Unitaid, respectively, to produce and sell the twice-a-year anti-HIV shot, lenacapavir, for $40 ...

Kampala — THE INDEPENDENT & AGENCIES | A new long-acting medicine that could make preventing HIV transition might soon be even for poor countries like Uganda thanks to agreements between producers and ...

A partnership will enable low-cost, generic lenacapavir for HIV prevention in LMICs, aiming to improve access and reduce infections significantly.

Hetero and Dr Reddy’s will be funded by the Gates Foundation and Unitaid to produce and sell the twice-a-year anti-HIV shot around R692 per person a year ...